Picture of ORIC Pharmaceuticals logo

ORIC — ORIC Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Oric Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

* Oric Pharmaceuticals Inc  ORIC.OQ  reported a quarterly
adjusted
loss of 45 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -50 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 41 cents per
share. Wall Street expected results to range from -44 cents
to -38 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Oric Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 45 cents​.
    * The company reported a quarterly loss of $31.96 million.
    * Oric Pharmaceuticals Inc shares had risen by 18.7% this
quarter and lost 8.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Oric
Pharmaceuticals Inc is $18.00 
This summary was machine generated from LSEG data August 13 at
01:08 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.41          -0.45          Missed
 Mar. 31 2024      -0.44          -0.37          Beat
 Dec. 31 2023      -0.49          -0.49          Met
 Sep. 30 2023      -0.46          -0.44          Beat

Recent news on ORIC Pharmaceuticals

See all news